Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01237561 · ClinicalTrials.gov registry record · NA

Translating The GOLD COPD Guidelines Into Primary Care Practice

A NA study, sponsored by Memorial Hospital of Rhode Island.

Completed
Registry status
NA
Development phase
3,593
Enrollment target

NCT01237561: Completed NA study, sponsored by Memorial Hospital of Rhode Island.

NCT01237561 is a NA study that has completed, run by Memorial Hospital of Rhode Island. The registered enrollment target is 3,593 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (156% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01237561, a NA study, has completed, sponsored by Memorial Hospital of Rhode Island.

COMPLETED
Registry status
NA
Development phase
3,593 participants
Enrollment target

Study Summary

This project will evaluate the translation of the Gold (the Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease) COPD guidelines into primary care practice. During phase I, a needs assessment will evaluate barriers and facilitators to implementation of COPD guidelines into clinical practice through focus groups of primary care patients and providers. Using formative evaluation and feedback from the focus groups, three tools will be developed, refined and pilot tested. The effectiveness of the materials developed in phase I will be tested in phase II (a randomized clinical trial conducted with one year of intervention within non-academic primary care practices) regarding physician performance of COPD guideline implementation and improvement in the clinically relevant outcomes (appropriate screening, diagnosis and management of COPD) compared to usual care.

Primary Outcome

An adherence tool will be developed and reviewed by an expert panel. They will review the suggested criterion and make recommendations regarding an item's status on the tool. The panel may also suggest additional criteria for inclusion in the tool. The tool will be modified based on expert consensus. Once the tool is finalized, a detailed algorithm will be developed for scoring the primary care practice data which will include an adherence score for each visit and an overall adherence score and

Interventions

  • OTHER provider support tools plus spirometer

Trial Details

FieldValue
Enrollment Target 3,593 participants
Start Date 2010-10
Est. Completion 2013-10-25
Phase NA

What the finished NCT01237561 record still lists

NCT01237561 is an interventional study that assigns participants to a tested intervention. Its 3,593 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (156% higher).

The record links to 0 conditions, and to 1 intervention - of which provider support tools plus spirometer is the first listed.

NCT01237561 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01237561 about?

NCT01237561 is a clinical study titled "Translating The GOLD COPD Guidelines Into Primary Care Practice". This project will evaluate the translation of the Gold (the Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease) COPD guidelines into primary care practice. During phase I, a needs assessment will evaluate barriers and facilitators to implementation...

What is the current status of trial NCT01237561?

This trial is currently completed. It is a NA study. The enrollment target is 3,593 participants. The study started on 2010-10. Estimated completion is 2013-10-25.

What interventions are being tested in trial NCT01237561?

The interventions under investigation include: provider support tools plus spirometer (OTHER).

Who is sponsoring clinical trial NCT01237561?

This trial is sponsored by Memorial Hospital of Rhode Island, which has 5 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01237561's enrollment target sits among peer trials

3,593 36th of 2000 higher than 1,965 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06088498 · 3,600 participants · Phase 2

    App for Reducing Cravings to Smoke

  • NCT06501118 · 3,600 participants · NA

    Optimizing Care in Critically Ill at UCHealth by Liberalizing the Target O2 in Mechanically-ventilated ICU Patients

  • NCT06919419 · 3,600 participants · NA

    HOTSPOT Study: Implement and Evaluate the PrEP (Pre-exposure Prophylaxis) Implementation Strategy

  • NCT07091032 · 3,600 participants · NA

    Building Connections

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01237561, the US trial registry maintained by the National Library of Medicine. NCT01237561 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.